Estd. 2007
With an outright purchase of Zeusmed Technologies Pvt. Ltd. in the year 2007, Inveniolife has strategically diversified in the field of high end and revolutionary technologies in medical equipments and diagnostics.
Our Goal
Our goal is to identify the most promising new technology companies around the globe and to introduce them in this emerging market.
Footprints
Based in the financial capital of India, Inveniolife has significant footprints across key locations in the country through a strongly knit network of channel partners and sub dealers.
Our Products
- Coronavirus Cell Lines
- NFAT Reporter Jurkat Cell Line
- ADCC Bioassay Effector Cell Lines
- CRISPR Cell Lines
- Car-T Cell Therapy
- Methyltransferases DNMT
- Methyltransferases PRMT
- Demethylases KDM
- CellBloks
- Lentiviruses
- OX40-HEK293
- Immunotherapy Cell Lines
- Cell Signalling Pathway Cell Lines
- Deacetylases HDAC
- Methyltransferases EZH
- Methyltransferases SETD
- Demethylases TET
- Arocell TK 210 Elisa
- SpikeSARS-CoV-2)Pseudotyped Lentivirus (Luc Reporter) Variants
- PD-L1 TCR CHO Cell Line
- Car-T Cell Lines
- Ion Channel Cell Lines
- Deacetylases SIRT
- Methyltransferases NSD
- Methyltransferases SMYD
- Bromodomains
Our Suppliers
Previous
Next